Seeking Alpha
You are currently following Mike Havrilla
Stop FollowingYou are no longer following Mike Havrilla
Mike Havrilla is an index developer, pharmacist, writer, and Co-Founder of BioMedReports.com with experience that includes online investing since August 1997 and writing for investors since April 2007 with a focus on the healthcare sector and small / micro-cap stocks. Mike holds Doctor of... More
- My business:
- ProActive HavRx BioFund
- My blog:
- BioMedReports.com FDA Calendar
- My book:
- ProActive HavRx Stock Indexes
StockTalks
-
$ABIO / Arca biopharma submits study protocol to address FDA CRL for Gencaro, gene-defined heart failure patients / http://tinyurl.com/y9ebfccabout 7 hours ago
-
ProActive Global Air Transport Index Up approx. 70% in past six months / http://bit.ly/76BhUHabout 8 hours ago
-
$FCSC.OB / Fibrocell Science FDA CRL, requesting more safety data for cell-based wrinkle treatment (azficel-T) / http://tinyurl.com/yaouwznabout 10 hours ago
Posts by Ticker
AAPL,
ABII,
ABIO,
ABT,
ABV,
ACAD,
ACCP.OB,
ACOR,
ACUR,
ACUS,
ADAM,
ADLS,
AET,
AEZS,
AFFY,
AGEN,
AGN,
ALKS,
ALNY,
ALPMF.PK,
ALTH,
ALXA,
AMAG,
AMGN,
AMLN,
AMRN,
ANPI,
APPA,
APPY,
ARDM.OB,
ARKTF.PK,
ARNA,
ARUXF.PK,
ARYX,
ATHN,
AUXL,
AVNR,
AZN,
BAX,
BAYRY.PK,
BCRX,
BDSI,
BFRM,
BIIB,
BIOD,
BMRN,
BMTI,
BMY,
BPAX,
BSX,
BVX,
C,
CADX,
CBMX,
CBST,
CELG,
CEPH,
CERN,
CGRB,
CHL,
CHTP,
CL,
CLDA,
CLDX,
CLRT,
CLSN,
CMCSA,
COV,
CPD,
CPSI,
CRGN,
CRME,
CRTX,
CRVW.PK,
CRXL,
CRXX,
CSCO,
CTIC,
CYPB,
CYTK,
CYTR,
CYTX,
DDSS,
DEF,
DGT,
DNDN,
DRRX,
DSCO,
DVY,
DYAX,
EBS,
ECLP,
EMIS,
ENDP,
EPIX,
ESALY.PK,
EURX,
EXAS,
FOLD,
FRX,
GE,
GENZ,
GERN,
GILD,
GIS,
GLD,
GMGMQ.PK,
GNBT,
GNTA,
GNVC,
GOOG,
GSK,
GTXI,
HEB,
HGSI,
HITK,
HLUKY.PK,
HOLX,
IART,
IBB,
ICAD,
IMGN,
IMMU,
INCY,
INSM,
IPXL,
ISIS,
ISTA,
JAV,
JAZZ,
JNJ,
KERX,
KFT,
KG,
KO,
LCI,
LH,
LLY,
LMT,
MAPP,
MAXY,
MCD,
MDCO,
MDRX,
MDT,
MEDX,
MELA,
MHS,
MIPI,
MITI,
MKGAY.PK,
MNKD,
MNTA,
MO,
MON,
MOT,
MRGE,
MRK,
MRX,
MTXX,
MYGN,
MYL,
NBS,
NEPH.OB,
NFLD,
NGSX,
NICXF.PK,
NIV,
NKOFF.PK,
NOVL,
NPSP,
NRIFF.PK,
NSPH,
NSRGY.PK,
NURO,
NVAX,
NVO,
NVS,
OGXI,
ONTY,
OREX,
OSIP,
OSIR,
OSTE,
OSUR,
PARD,
PBE,
PEP,
PFE,
PG,
PGNX,
PLX,
PM,
POZN,
PPDI,
PPHM,
PRX,
PSDV,
PTIE,
PXSL,
QCOR,
QGEN,
QSII,
RBGPF.PK,
RHHBY.PK,
RIGL,
RIMM,
RMTI,
RPRX,
S,
SGEN,
SGP,
SHPGY,
SKYEF.PK,
SLXP,
SNTS,
SNY,
SO,
SOMX,
SPPI,
SPY,
SQNM,
STEM,
SUPG,
SVNT,
T,
TDLP.OB,
TEF,
TESS,
TEVA,
THOR,
THRX,
THTCF.PK,
TKPHY.PK,
TRGT,
TRIB,
TSPT,
UCBJF.PK,
UNH,
UTHR,
VION.OB,
VNDA,
VPHM,
VVUS,
VZ,
WMT,
WPI,
WYE,
XBI,
XLP,
XLU,
XLV,
XNPT,
XOM,
XOMA,
YMI,
ZIXI
Latest Comments
-
Nickelhead on Quantum Immunologics: Developing Universal Therapeutic Cancer Vaccine i have been following this company for a while ...
-
dual cit on NF Energy (OTC: NFEC.OB): 3Q09 Revs $7.57M, EPS $0.16 but this is ragtime. Mike's a pharmacist - NOT ...
-
dual cit on BioMedReports.com FDA Calendar Overview Why in god's name would anyone subscribe to inf...
-
437339 on NF Energy (OTC: NFEC.OB): 3Q09 Revs $7.57M, EPS $0.16 User460702He might as well move from bio -med i...
-
437339 on Echo Therapeutics: Positive Developments for Needle-Free Diabetes Monitoring System Re One can have near perfect , within normal li...
Most Commented
- BioMedReports.com Mention in BusinessWeek (7 Comments)
- Sequenom Splattered, EXACT Sciences on the Rise (3 Comments)
- Who Will Take GM's Place in the Dow? (3 Comments)
- 13 Extreme FDA Trades: BioMedReports.com 6/1/09 Update (3 Comments)
- Mentor Capital: A Stealth Cancer Immunotherapy Play (3 Comments)
Posts by Themes
allos therapeutics,
ANDA,
ASCO,
Avastin,
BIO.PA,
BioAlliance,
biogenerics,
biomed,
BioMedReports.com,
biotech,
BLA,
Botox,
cancer,
cancer biotech,
cancer stock,
China,
cholesterol,
Clean Energy,
Clinical Trial,
Clinical Trial Calendar,
Clinical Trials,
clinical trials,
consumer staples,
Crestor,
DAVANAT,
defensive,
Dendreon,
Diabetes,
Discovery Labs,
dividends,
Dolphin Secure,
Dysport,
Enablex,
ETF Innovators,
Extreme Trades,
Facebook,
FDA,
fda,
FDA Calendar,
Feraheme,
Genentech,
generic,
Generic Drugs,
Global Pharma,
GTx,
Health IT,
Health IT Index,
healthcare,
Impax Labs,
Impax Pharma,
Infrastructure,
Internet,
Loramyc,
medical device,
mobile broadband,
molecular diagnostics,
MySpace,
NDA,
Nickelodeon,
Novartis,
Osiris,
PDUFA,
pdx,
pharma,
Phase 3,
Phase 3 ,
Phase 3 Clinical Trial,
PolyHeme,
pralatrexate,
Pro Pharma,
Prochymal,
Provenge,
regenerative medicine,
Reloxin,
rnai,
Sequenom,
SEQureDx,
SFP,
SIMPONI,
small-cap,
social networking,
Solzira,
Stem Cell Index,
stem cell index,
Stem Cells,
stem cells,
Strativa,
Surfaxin,
swine flu virus,
telavancin,
TriLipix,
vaccine,
virus,
Watson,
wireless
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
-
Instablogged Stocks
Stocks that instabloggers have most recently written about -
Latest Instablog Posts
- 1 Europe's Weaknesses Grossly Exaggerated by U...
- 2 SAB No. 99 Materiality Provides An Adequate ...
- 3 12-22-09 - BUY (PRGS) ON THE FIRST CLOSE ABO...
- 4 Interview with Jeff Borack: Why This Hedge F...
- 5 Portfolio Update
-
Top Instabloggers
See all Top Instabloggers » Top StockTalkers »


















Full Index of Posts 298 posts, page 1 of 9
Mentor Capital Plans Early ’10 Launch of Cancer Vaccine Active Index Fund
ProActive HavRx Stock Indexes
BioMed Research Updates: ARRY, ACCP.OB, GCKO.PK, MCLN.OB
New Era Begins for NeoStem Following China Acquisition
Access Pharma Update, CEO Interview
Unilife Medical: Recent Sell-Off Unwarranted, Quick Rebound Likely
Cytori’s (NASDAQ: CYTX) Natural Celution for Breast Reconstruction
BioMed Updates Dec 6-8
BioMedReports.com Healthcare Stock Indexes
BioMed Updates: ELTP.OB, SOMX, STEM, GERN, ASTM, VRTX, CYTR, IMUC.OB, JAV
ImmunoCellular Notches Deal for New Cancer Stem Cell Vaccine Target
BioMed Updates: JNJ, DYAX, HEB, SNTS, PLX, PFE, CVM, GILD, ENDP, TEVA, AMGN
BioMed News Bytes: Merck KGaA, BioMarin, Cytori, Theravance
BioMedReports.com FDA Calendar Overview
Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: DNDN)
Unilife (UNIFF.PK) CEO Video Interview on CNBC
BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: LPTN.OB)
Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife
BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO
Diabetes Care: Global Investing Opportunities
BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen
BioMed News Bytes: AstraZeneca, Delcath, Unilife
Echo Therapeutics: Positive Developments for Needle-Free Diabetes Monitoring System
Epinex Diagnostics: A New Paradigm for Diabetic Testing
BioMed News Bytes: GeoVax, Cerus, Discovery Labs, NeurogesX
NeurogesX (NASDAQ: NGSX) Receives FDA Approval for Qutenza
BioMed News Bytes: Genzyme, OSI Pharma, Pfizer, Seattle Genetics
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
NF Energy (OTC: NFEC.OB): 3Q09 Revs $7.57M, EPS $0.16
Waste2Energy (OTC: WTEZE.OB): A Local, Green Solution to Waste Disposal
Access Pharma: MuGard Launch Expected 1Q10
ImmunoCellular: Griffin Maintains Buy Rating with $3.25 Target
EXACT Sciences: Buy and Hold for Long-Term Upside
ProActive HavRx Stock Indexes: Highlights and Opportunities
Protox Presents Data, Awaits Key Results for PRX302